Gallacher Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$440K Sell
1,733
-724
-29% -$169K 0.25% 130
2026
Q1
$601K Hold
2,457
0.23% 128
2025
Q4
$509K Hold
2,457
0.2% 148
2025
Q3
$456K Hold
2,457
0.18% 185
2025
Q2
$375K Sell
2,457
-1
-0% -$154 0.17% 172
2025
Q1
$408K Sell
2,458
-8
-0.3% -$1.25K 0.2% 152
2024
Q4
$357K Buy
2,466
+6
+0.2% +$930 0.18% 159
2024
Q3
$399K Sell
2,460
-121
-5% -$19.3K 0.18% 141
2024
Q2
$377K Sell
2,581
-513
-17% -$76.3K 0.2% 146
2024
Q1
$489K Sell
3,094
-476
-13% -$75.8K 0.25% 81
2023
Q4
$560K Buy
3,570
+1,001
+39% +$153K 0.31% 46
2023
Q3
$400K Buy
2,569
+4
+0.2% +$660 0.25% 88
2023
Q2
$425K Buy
2,565
+5
+0.2% +$807 0.25% 100
2023
Q1
$397K Sell
2,560
-37
-1% -$5.97K 0.24% 109
2022
Q4
$459K Buy
+2,597
New +$448K 0.28% 74

Other funds holding JNJ

Gallacher Capital Management's JNJ Position: Q2 2026 in Review

Gallacher Capital Management reduced its Johnson & Johnson (JNJ) stake by 29% in Q2 2026, selling an estimated $169K and leaving 1,733 shares worth $440K. The position accounts for 0.25% of the portfolio, ranked #130.

Gallacher Capital Management first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $601K in Q1 2026. 1,419 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gallacher Capital Management held 1,733 shares of Johnson & Johnson worth $440K as of Q2 2026.
  • Gallacher Capital Management sold 724 Johnson & Johnson shares in Q2 2026, an estimated $169K.
  • Johnson & Johnson made up 0.25% of Gallacher Capital Management's portfolio in Q2 2026, its #130 holding.
  • Gallacher Capital Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Gallacher Capital Management's Johnson & Johnson position peaked at $601K in Q1 2026.
  • 1,419 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.